Last reviewed · How we verify
NCT05173766
Ergonomic Considerations on Musculoskeletal Disorders and Posture in Software Developers.
NA trial testing ergonomic principls in Musculoskeletal Disorders in 323 participants. Completed in 10 March 2022.
10 February 2022
Quick facts
| Lead sponsor | Riphah International University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 323 |
| Start date | 10 November 2021 |
| Primary completion | 10 February 2022 |
| Estimated completion | 10 March 2022 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- ergonomic principls
Conditions studied
- Musculoskeletal Disorders — all drugs for Musculoskeletal Disorders →
Sponsor
Riphah International University
Who can join
Adults 25 to 40, any sex, with Musculoskeletal Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The human and computer interface is becoming increasingly intuitive, but for the inexperienced user still poses formidable problems. Musculoskeletal symptoms of VDU users are believed to have a multifactorial aetiology. Software developers don't have knowledge of ergonomic principles. Faulty postures had an effect on posture.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05173766
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Musculoskeletal Disorders
Currently open trials in the same condition.
- NCT07137754 — Effect and Cost of a Physiotherapy-led Care Model in Emergency Departments for Patients With Minor Musculoskeletal Injur · NA · recruiting
- NCT06451120 — Platelet Rich Plasma Injections In Young And Old Human Subjects · Phase 2 · recruiting
- NCT04684602 — Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions · Phase 1, PHASE2 · recruiting
Other Riphah International University trials
Trials by the same sponsor.
- NCT07579585 — Effects of Photobiomodulation in Hemophilia Patients. · NA · recruiting
- NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
- NCT07484477 — Sedentary Behavior Modification, Cardiopulmonary Function & QOL Post Cardiac Surgery Patients. · NA · not yet recruiting
- NCT07438587 — Comparative Effects of Cadence Training vs Elliptical Training in Cricketers · NA · not yet recruiting
- NCT07484399 — Comparing Effects of HIIT and MICT on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05173766 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Riphah International University
- Last refreshed: 12 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05173766.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing